How do you identify patients with CTCL who are likely to be highly responsive to ECP?

How do you identify patients with CTCL who are likely to be highly responsive to ECP?

How do you identify patients with CTCL who are likely to be highly responsive to ECP?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Julia Scarisbrick, MD

Julia Scarisbrick, MD

Dr. Julia Scarisbrick
Consultant Dermatologist & Cutaneous Lymphoma
Lead at the University Hospital
Birmingham, UK